Synthalis
Synthalis is an AI-native pharmaceutical company focused on transforming innovation from Africa and the UK into global assets. They operate in business areas such as Medical Devices and Novel Ligands. Their product, Oxylert, is designed to improve focus and maximize performance by detecting user drowsiness and circulating ionized oxygen. The team comprises scientists, engineers, clinicians, and technologists leveraging AI for drug discovery and patient outcomes. Synthalis Limited is registered in London, UK, with company registration number 16406203.
Synthalis
Synthalis is an AI-native pharmaceutical company focused on transforming innovation from Africa and the UK into global assets. They operate in business areas such as Medical Devices and Novel Ligands. Their product, Oxylert, is designed to improve focus and maximize performance by detecting user drowsiness and circulating ionized oxygen. The team comprises scientists, engineers, clinicians, and technologists leveraging AI for drug discovery and patient outcomes. Synthalis Limited is registered in London, UK, with company registration number 16406203.